In Brief: Telectronics
This article was originally published in The Gray Sheet
Telectronics: Resumes manufacture and shipment of cardiac pacemakers and pacemaker leads for distribution within the U.S., the firm announces June 21. Telectronics agreed to stop selling its devices in the U.S. in May 1995 under a consent decree signed with FDA that required the firm to make corrections to good manufacturing practices deficiencies at its Miami Lakes, Florida facility ("The Gray Sheet" May 29, I&W-10). Telectronics says it is now in compliance with GMPs...
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.